Six ways to utilize real-world evidence
Real-world evidence is gaining interest – and fast. The phenomenon is global. The growth of...
All articles
-
-
Prototype of a Gaucher disease point-scoring system successfully tested in Finnish patients
A prototype of a Gaucher disease point-scoring system (PSS), originally established by the Gaucher Earlier...
-
From todays treatment to future medicine
Year 2021 will be the year of Real-World Evidence. Data obtained from patients’ treatment has...
-
What is Health from Data?
This March marks the start of my new blog – Health From Data. Here I...
-
New RWE themed blog to start in March!
Interested in RWE research? Health from data is the first real-world evidence themed blog written...
-
Finnish ecosystem supports the use of real world evidence (RWE)
Real World Evidence (RWE) ecosystem in Finland Real world data (RWD) is defined by FDA...
-
Pharmaceutical Pricing and Market Access of Medicine Products in Finland
Medicines in Finland are divided into medicines in ambulatory and hospital care. This article describes these two routes and provides information of the market access options and pricing system in Finland. Updated annually.
-
My Migraine Voice -survey reveals the emotional and social burden of migraine in Finland
Migraine is a disabling headache disorder that places a significant burden both for the patients...
-
Navigating the Real World Data (RWD) landscape in Finland
The real world data (RWD) landscape in Finland offers globally unique data and possibilities to...
-
Specific patient characteristics of heart failure across the LVEF range highlight the importance of effective treatments to reduce hospitalizations
The proportion of patients hospitalized for heart failure (HF) with preserved left ventricular ejection fraction...
-
The results of a data analysis – there’s a lot to improve in the treatment of migraine patients
A unique study on the treatment results of migraine patients led Terveystalo to develop the...
-
Multimorbidity across multiple ICD-10 codes should be considered when treating migraine patients
In migraine, co-occurrence of two or more diseases or conditions is typical. Asthma and allergies,...
-
The Burden of Idiopathic Pulmonary Fibrosis (IPF) in Finland
A new real world evidence study on Idiopathic pulmonary fibrosis (IPF) describes the high disease...
-
The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization
Chronic obstructive pulmonary disease is one of the leading causes of mortality and morbidity worldwide....
-
Machine learning based tools in the analysis of RWD; focus on image recognition
Healthcare provides various types of Real World Data (RWD) that can be used to generate...
-
Migraine comorbidity and phenotypic disease networks in occupational health care
The Burden of Migraine Study continues The study ‘Migraine comorbidity and phenotypic disease networks in...
-
The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization
Medaffcon’s new real-world evidence study on the burden of adult asthma in Finland demonstrates the...
-
HIMSS & Health 2.0 European Conference
HIMSS & Health 2.0 European conference took place on 11-13.6.2019 in Helsinki. 3 000 professionals...
-
Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use
The high mortality rate of heart failure (HF) patients compared to age-matched controls highlights the...
-
Migraine nearly doubles the amount of healthcare visits and sick-leave days
New real-world evidence (RWE) based study shows that migraine nearly doubles the amount of healthcare...
-
Finnish pricing and reimbursement landscape
Pricing and reimbursement in Finland Pharmaceuticals Pricing Board (PPB), operating under the Ministry of Social...
-
Medaffcon’s article in the latest biobanking magazine
Medaffcon pioneering biobank and real-world evidence research efforts in Finland The newest Biobanking in Finland...
-
BC Platforms and Medaffcon Join Forces to Streamline Collaboration Between Biobanks and Researchers
BC Platforms AG, a world leader in genomic data management and analytics, today announces that...
-
A survey conducted by Medaffcon Oy and the University of Eastern Finland reviewed the operational status of Finnish hospital biobanks
Recently established Finnish hospital biobanks have launched new research activity in Finland. Through the Finnish biobank...
-
Managed entry agreements facilitate the access of new medicines
Public health authorities and pharmaceutical companies have searched for alternative funding formulas to share the...
-
AI-based tools for mining electronic health record data
Analyzing electronic health record (EHR) data has already provided us with new insights in medical...
-
Finnish hospital biobanks promote research both nationally and internationally
Medaffcon has in collaboration with the University of Eastern Finland assessed the operational status of...
-
Real world evidence (RWE) supported health technology assessment (HTA)
Demonstrating that a health technology, e.g. a product, procedure or any intervention, is worth its...
-
Unique platform promotes efforts to advance customized cancer care
Medaffcon has created a unique platform that collects information about innovative Finnish efforts and technologies...
-
Possibilities of machine learning and artificial intelligence in RWE studies
Currently huge piles of health care data have been collected in Finland through national, regional...
-
Risk-Sharing Agreements in Finland
Risk-sharing agreements (RSA) are one of the most interesting and debated topics in the Finnish...
-
Conditional reimbursement facilitates the introduction of new treatments
Learn about conditional reimbursement from the interview with CEO Jarmo Hahl, Medaffcon Oy. There’s often...
-
Unique mapping on personalised cancer care
A top-level ecosystem emerging in Finland Medaffcon is currently mapping the most advanced practices in...
-
Medaffcon’s new cooperation project aims at better utilisation of biobank health data
Medaffcon is known in Finland as the forerunner of commercial biobank studies. Strong cooperation network...
-
Cancer Precision Medicine in Finland – Current and Future Possibilities for Personalized Patient Care
BACKGROUND Cancer precision medicine is currently raising considerable interest in healthcare. Healthcare is getting closer...
-
Risk Sharing Models in Finnish Hospitals 2017-study report now available!
Like already mentioned in my previous post it is known that different Risk-Sharing Models have...
-
Risk Sharing Models in Finnish Hospitals 2017 -study
As we all know different Risk-Sharing Models (RSM) have been varyingly in use in different...
-
Indicators for Assessing Treatment Effectiveness
Pharma Industry Finland commissioned a report from Medaffcon concerning how effectiveness could be assessed in...
-
Risk Sharing Models – Three perspectives
In our customer event in April, we examined risk-sharing models from three different perspectives. Director...
-
RWE sources now and in the future
In the Medaffcon customer evening organised in April 2017, we went through data sources related...
-
Corporate Acquisition of Tamro and Medaffcon
The corporate acquisition opens up new opportunities for the utilisation of medical information in the...
-
Medaffcon’s trainee culture
At Medaffcon, we have invested in young professionals’ career development for years. By employing trainees,...
-
Medaffcon and Pharma Industry Finland begin a study in order to produce indicators for measuring effectiveness in healthcare
The assessment of treatment effectiveness should hold a central role in healthcare, in order to...
-
Welcome Tomi Vahevaara and Maija Wolf
Medaffcon’s growth has not slowed down in January. In the beginning of the month both...
-
Welcome Tanja Karvonen!
Tanja joined Medaffcon’s Market Access team in November 2016 Tanja gained her most recent work...